In the evening of October 22, 2009, the Bureau of Pharmaceutical Affairs informed the Central Epidemic Command Center (CECC) the clinical trial results of Adimmune’s pandemic influenza A (H1N1) vaccine and records of the Advisory Committee on Pharmaceuticals meeting.The vaccine produced by Adimmune can reduce the chances of getting pandemic influenza A (H1N1) by 70% in healthy adults.The effectiveness and side effects of Adimmune’s H1N1 vaccine is similar to that of Novartis’s H1N1 vaccine.Therefore, only one single dose of Adimmune’s H1N1 vaccine will provide enough protection against pandemic influenza A (H1N1) in adults aged 18 and older. The number of doses of Adimmune’s H1N1 vaccine to be administered to children aged between 1 and 18 will be determined by the results of Adimmune’s human clinical trials conducted in children.

On October 23, 2009, the Taiwan Centers for Disease Control (Taiwan CDC) and local health bureaus in the nation organized the fourth meeting for discussion of the immunization of pandemic influenza A (H1N1) vaccine.Besides discussing the immunization campaign to be held on November 1, 2009, representatives from local health bureaus all indicated that the immunization of infants scheduled to be held on November 9, 2009 is also ready.The local health bureaus will notify parents of the infants concerning the immunization schedule and the infants will receive immunization at local health centers.The list of contracted hospitals administering pandemic influenza A (H1N1) vaccine will be announced a week prior to the start of the immunization process.

On the other hand, Director Kuo of Taiwan CDC mistakenly announced that the number of pandemic influenza A (H1N1) immunization till the end of the year would be ten million at the Legislative Yuan the other day when he meant to say the number of vaccine that would be available by the end of year would be ten million.In addition, CECC announced that the number of pandemic influenza A (H1N1) immunization is expected to reach 7.5 million by the end of this year.